Trends in Insulin Prescribing for Patients With Diabetes During the COVID-19 Pandemic in the US

JAMA Netw Open. 2021 Nov 1;4(11):e2132607. doi: 10.1001/jamanetworkopen.2021.32607.

Authors

Ismaeel Yunusa^{1

2}, Bryan L Love^{1

2}, Chao Cai^{1

2}, Tessa Hastings^{1

2}, Claiborne E Reeder^{1

2

3}, Elizabeth W Blake², Cynthia Phillips²

Affiliations

¹ Center for Outcomes Research and Evaluation, University of South Carolina College of Pharmacy, Columbia.
² Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Columbia.
³ Kennedy Pharmacy Innovation Center, University of South Carolina College of Pharmacy, Columbia.

Abstract

This cross-sectional study compares the number of insulin prescriptions filled before and during the COVID-19 pandemic.

MeSH terms

Adult
COVID-19 / epidemiology
Child
Cross-Sectional Studies
Diabetes Mellitus / drug therapy
Health Services Accessibility
Humans
Insulin / therapeutic use*
Pandemics
Practice Patterns, Physicians' / statistics & numerical data*
Retrospective Studies
SARS-CoV-2

Substances

Insulin